Frontlight ResearchEarly access
Trial site
MoCA Research and Innovation Inc.
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Phase
- Phase 34 trials
- Status
- Active, not recruiting2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Biogen1 trial
- Bristol-Myers Squibb1 trial
Running trials
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026